If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Reduction in Net Asset Value

24 Jun 2013 17:25

RNS Number : 7493H
China Private Equity Inv Hldgs Ld
24 June 2013
 



24 June 2013

China Private Equity Investment Holdings Limited

 

("CPE" or the "Company")

 

Reduction in Net Asset Value

The Company announces that in its preliminary results for 31 December 2012, due for release later this week, it is likely to report a reduction in its consolidated net asset value to US$ 23.2m, equivalent to US$0.30 per share. This represents a 29.7% decrease from the last reported net asset value of US$33.0 million as at 30 June 2012, equivalent to US$0.43 per share.

This expected reduction in net asset value is mainly due to decreases in fair value of the CPE's stakes in Enfinium and Fortel. The value of the CPE's holding in Enfinium was reduced by US$3.34 million, as announced on 15 October 2012, following the exchange of the CPE's shares for 127,000 shares in AIP Global, Enfinium's parent company. During the recent audit process for the year-end financial statements, the Company auditors have also determined to reduce the carrying value of the investment in Fortel by US$5.88m.

Further details of the Company's financial performance for the year ended 31 December 2012 will be contained in the Company's preliminary results which will be released later this week.

For further information, please visit www.cpe-invest.comor contact:

Maria Leung

China Private Equity Investment Holdings Ltd:

 

+852 2801 6770

 

Azhic Basirov / Siobhan Sergeant,

Smith & Williamson Corporate Finance Ltd:

 

+44 (0) 20 7131 4000

 

Allan Piper

First City Public Relations (Hong Kong):

 

+852 2854 2666

 

Simon Hudson

Tavistock Communications (London):

 

+44 (0) 20 7920 3170

 

www.cpe-invest.com

Ticker symbol:

London - CPEH

Frankfurt - AA1JBE5

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGZVVDFGFZM
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.